Abstract
The thymic epithelial tumors represent a heterogeneous group of thoracic cancers that originate in the thymus and are in the anterior mediastinum (de Jong WK, Blaauwgeers JL, Schaapveld M et al. Eur J Cancer 44:123–130, 2008). They are classified according to the World Health Organization (WHO) in Thymoma and Thymic Carcinoma (Marx A, Chan JK, Coindre JM et al. J Thorac Oncol 10:1383–1395, 2015). Thymomas may spread locally, but thymic carcinomas are much more aggressive (Proceedings of the First International Conference on Thymic Malignancies. August 20–21, 2009. Bethesda, Maryland, USA. J Thorac Oncol 2010;5:S259–S370, 2009).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
de Jong WK, Blaauwgeers JL, Schaapveld M et al (2008) Thymic epithelial tumours: a population-based study of the incidence, diagnostic procedures and therapy. Eur J Cancer 44:123–130
Marx A, Chan JK, Coindre JM et al (2015) The 2015 World Health Organization Classification of Tumors of the Thymus: continuity and changes. J Thorac Oncol 10:1383–1395
Proceedings of the First International Conference on Thymic Malignancies. August 20–21, 2009. Bethesda, Maryland, USA. J Thorac Oncol 2010;5:S259–S370
Rashid OM, Cassano AD, Takabe K (2013) Thymic neoplasm: a rare disease with a complex clinical presentation. J Thorac Dis 5:173–183
Detterbeck FC, Zeeshan A (2013) Thymoma: current diagnosis and treatment. Chin Med J 126:2186–2191
Huang J, Rizk NP, Travis WD et al (2009) Comparison of patterns of relapse in thymic carcinoma and thymoma. J Thorac Cardiovasc Surg 138:26–31
Eng TY, Fuller CD, Jagirdar J et al (2004) Thymic carcinoma: state of the art review. Int J Radiat Oncol Biol Phys 59:654–664
Safieddine N, Liu G, Cuningham K et al (2014) Prognostic factors for cure, recurrence and long-term survival after surgical resection of thymoma. J Thorac Oncol 9:1018
Litvak AM, Woo K, Hayes S et al (2014) Clinical characteristics and outcomes for patients with thymic carcinoma: evaluation of Masaoka staging. J Thorac Oncol 9:1810–1815
Detterbeck FC, Parsons AM (2011) Management of stage I and II thymoma. Thorac Surg Clin 21:59–67, vi–vii
Moran CA, Suster S (2008) Thymic carcinoma: current concepts and histologic features. Hematol Oncol Clin North Am 22:393–407
DeVita VT Jr, Lawrence TS, Rosenberg SA. Cancer: principles and practice of oncology, 10th edn
Suster S, Rosai J (1991) Thymic carcinoma. A clinicopathologic study of 60 cases. Cancer 67:1025–1032
Bernard C, Frih H, Pasquet F et al (2016) Thymoma associated with autoimmune diseases: 85 cases and literature review. Autoimmun Rev 15:82–92
Ruffini E, Venuta F (2014) Management of thymic tumors: a European perspective. J Thorac Dis 6(Suppl 2):S228–S237
Evoli A, Lancaster E (2014) Paraneoplastic disorders in thymoma patients. J Thorac Oncol 9(Suppl 2):S143–S147
Blossom GB, Ernstoff RM, Howells GA et al (1993) Thymectomy for myasthenia gravis. Arch Surg 128:854–862
Marx A, Hohenberger P, Hoffmann H et al (2010) The autoimmune regulator AIRE in thymoma biology: autoimmunity and beyond. J Thorac Oncol 5(Suppl 4):S266–S272
Girard N, Ruffini E, Marx A et al (2015) Thymic epitelial tumours: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 26(Supplement 5):v40–v55
NCCN. Clinical practice guidelines in oncology. Thymic malignancies. V.1.2017. www.nccn.org (Date last accessed 16 Nov 2017)
Falkson CB, Bezjak A, Darling G et al (2009) The management of thymoma: a systematic review and practice guideline. J Thorac Oncol 4:911–919
Morrissey B, Adams H, Gibbs AR et al (1993) Percutaneous needle biopsy of the mediastinum: review of 94 procedures. Thorax 48:632–637
Carter BW, Marom EM, Detterbeck FC (2014) Approaching the patient with an anterior mediastinal mass: a guide for clinicians. J Thorac Oncol 9(Suppl 2):S102–S109
Kaira K, Endo M, Abe M et al (2010) Biologic correlation of 2-[18F]-fluoro-2-deoxy-D- glucose uptake on positron emission tomography in thymic epithelial tumors. J Clin Oncol 28:3746–3753
Fukai I, Funato Y, Mizuno T et al (1991) Distribution of thymic tissue in the mediastinal adipose tissue. J Thorac Cardiovasc Surg 101:1099–1102
Wang H, Sima CS, Beasley MB et al (2014) Classification of thymic epithelial neoplasms is still a challenge to thoracic pathologists: a reproducibility study using digital microscopy. Arch Pathol Lab Med 138:658–663
Kondo K, Yoshizawa K, Tsuyuguchi M et al (2004) WHO histologic classification is a prognostic indicator in thymoma. Ann Thorac Surg 77:1183–1188
Suster S, Moran CA (2006) Thymoma classification: current status and future trends. Am J Clin Pathol 125:542–554
Hsu CP, Chan CY, Chen CL et al (1994) Thymic carcinoma: ten years’ experience in twenty patients. J Thorac Cardiovasc Surg 107:615–620
Marx A, Ströbel P, Badve SS et al (2014) ITMIG consensus statement on the use of the WHO histological classification of thymoma and thymic carcinoma: refined definitions, histological criteria, and reporting. J Thorac Oncol 9:596–611
Ionescu DN, Sasatomi E, Ciepley K et al (2005) Protein expression and gene amplification of epidermal growth factor receptor in thymomas. Cancer 103:630–636
Strobel P, Hartmann M, Jakob A et al (2004) Thymic carcinoma with overexpression of mutated KIT and the response to imatinib. N Engl J Med 350:2625–2626
Masaoka A (2010) Staging system of thymoma. J Thorac Oncol 5:S304–S312
Detterbeck F, Youssef S, Ruffini E, Okumura M (2011) A review of prognostic factors in thymic malignancies. J Thorac Oncol 6(Suppl 3):S1698–S1704
Detterbeck FC, Stratton K, Giroux D et al (2014) The IASLC/ITMIG thymic epithelial tumors staging project: proposal for an evidence-based stage classification system for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol 9(Suppl 2):S65–S72
Ruffini E, Detterbeck F, Van Raemdonck D et al (2014) Tumours of the thymus: a cohort study of prognostic factors from the European Society of Thoracic Surgeons database. Eur J Cardiothorac Surg 46:361–368
Huang J, Detterbeck FC, Wang Z, Loehrer PJ Sr (2011) Standard outcome measures for thymic malignancies. J Thorac Oncol 6(Suppl 3):S1691–S1697
Ried M, Potzger T, Sziklavari Z et al (2014) Extended surgical resections of advanced thymoma Masaoka stages III and IVa facilitate outcome. Thorac Cardiovasc Surg 62:161–168
Bhora FY, Chen DJ, Detterbeck FC et al (2014) The ITMIG/IASLC thymic epithelial tumors staging project: a proposed lymph node map for thymic epithelial tumors in the forthcoming 8th edition of the TNM classification of malignant tumors. J Thorac Oncol 9(Suppl 2):S88–S96
Detterbeck FC, Moran C, Huang J et al (2011) Which way is up? Policies and procedures for surgeons and pathologists regarding resection specimens of thymic malignancy. J Thorac Oncol 6(Suppl 3):S1730–S1738
Hamaji M, Ali SO, Burt BM (2014) A meta-analysis of surgical versus nonsurgical management of recurrent thymoma. Ann Thorac Surg 98:748
Utsumi T, Shiono H, Kadota Y et al (2009) Postoperative radiation therapy after complete resection of thymoma has little impact on survival. Cancer 115:5413–5420
Korst RJ, Kansler AL, Christos PJ, Mandal S (2009) Adjuvant radiotherapy for thymic epithelial tumors: a systematic review and meta-analysis. Ann Thorac Surg 87:1641–1647
Chen YD, Feng QF, Lu HZ et al (2010) Role of adjuvant radiotherapy for stage II thymoma after complete tumor resection. Int J Radiat Oncol Biol Phys 78:1400–1406
Weksler B, Shende M, Nason KS et al (2012) The role of adjuvant radiation therapy for resected stage III thymoma: a population-based study. Ann Thorac Surg 93:1822–1828
Gomez D, Komaki R, Yu J et al (2011) Radiation therapy definitions and reporting guidelines for thymic malignancies. J Thorac Oncol 6(Suppl 3):S1743–S1748
Omasa M, Date H, Sozu T et al (2015) Postoperative radiotherapy is effective for thymic carcinoma but not for thymoma in stage II and III thymic epithelial tumors: the Japanese Association for Research on the Thymus Database Study. Cancer 121:1008–1016
Kim ES, Putnam JB, Komaki R et al (2004) Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report. Lung Cancer 44:369–379
Hassan M, Seoud DE (2009) Multimodality treatments in locally advanced stage thymomas. Hematol Oncol Stem Cell Ther 2:340–344
Loehrer PJ Sr, Chen M, Kim K et al (1997) Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial. J Clin Oncol 15:3093–3099
Korst RJ, Bezjak A, Blackmon S et al (2014) Neoadjuvant chemoradiotherapy for locally advanced thymic tumors: a phase II, multi-institutional clinical trial. J Thorac Cardiovasc Surg 147:36–44
Wright CD, Choi NC, Wain JC et al (2008) Induction chemoradiotherapy followed by resection for locally advanced Masaoka stage III and IVA thymic tumors. Ann Thorac Surg 85:385–389
Attaran S, McCormack D, Pilling J, Harrison-Phipps K (2012) Which stages of thymoma benefit from adjuvant chemotherapy post-thymectomy? Interact Cardiovasc Thorac Surg 15:273–275
Loehrer PJ Sr, Kim K, Aisner SC et al (1994) Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group. J Clin Oncol 12:1164–1168
Lemma GL, Lee JW, Aisner SC et al (2011) Phase II study of carboplatin and paclitaxel in advanced thymoma and thymic carcinoma. J Clin Oncol 29:2060–2065
Giaccone G, Ardizzoni A, Kirkpatrick A et al (1996) Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma. A phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol 14:814–820
Loehrer PJ Sr, Jiroutek M, Aisner S et al (2001) Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial. Cancer 91:2010–2015
Palmieri G, Merola G, Federico P et al (2010) Preliminary results of phase II study of capecitabine and gemcitabine (CAP-GEM) in patients with metastatic pretreated thymic epithelial tumors (TETs). Ann Oncol 21:1168–1172
Loehrer PJ, Yiannoutsos CT, Dropcho S et al (2006) A phase II trial of pemetrexed in patients with recurrent thymoma or thymic carcinoma. J Clin Oncol 24(Suppl 18):abstr 7079
Lara PN Jr, Bonomi PD, Faber LP (1996) Retreatment of recurrent invasive thymoma with platinum, doxorubicin, and cyclophosphamide. Chest 110:1115–1117
Loehrer PJ Sr, Wang W, Johnson DH et al (2004) Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: an Eastern Cooperative Oncology Group Phase II Trial. J Clin Oncol 22:293–299
Koizumi T, Takabayashi Y, Yamagishi S et al (2002) Chemotherapy for advanced thymic carcinoma: clinical response to cisplatin, doxorubicin, vincristine, and cyclophosphamide (ADOC chemotherapy). Am J Clin Oncol 25:266–268
Rajan A, Girard N, Marx A (2014) State of the art of genetic alterations in thymic epithelial tumors. J Thorac Oncol 9(Suppl 2):S131–S136
Thomas A, Rajan A, Berman A et al (2015) Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial. Lancet Oncol 16:177–186
Girard N (2012) Chemotherapy and targeted agents for thymic malignancies. Expert Rev Anticancer Ther 12:685–695
Salter JT, Lewis D, Yiannoutsos C et al (2008) Imatinib for the treatment of thymic carcinoma. J Clin Oncol 26(15s suppl):abstr 8116
Zucali PA, De Pas TM, Palmieri G et al (2014) Phase II study of everolimus in patients with thymoma and thymic carcinoma previously treated with cisplatin-based chemotherapy. J Clin Oncol 32(5s suppl):abstr 7527
Haniuda M, Kondo R, Numanami H et al (2001) Recurrence of thymoma: clinicopathological features, re-operation, and outcome. J Surg Oncol 78:183
Welsh JS, Wilkins KB, Green R et al (2000) Association between thymoma and second neoplasms. JAMA 283:1142
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Landgraf, M.M., Guimarães, D.P., Tadokoro, H., De Mello, R.A. (2019). Epithelial Thymic Neoplasms. In: De Mello, R., Mountzios, G., Tavares, Á. (eds) International Manual of Oncology Practice. Springer, Cham. https://doi.org/10.1007/978-3-030-16245-0_12
Download citation
DOI: https://doi.org/10.1007/978-3-030-16245-0_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-16244-3
Online ISBN: 978-3-030-16245-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)